Eclipse Fundraiser to Help Thoroughbred Aftercare Program
The Blood-Horse Staff
December 26, 2012
The aftercare program matches retired racehorses with owners who will ensure their health and safety.
The aftercare program matches retired racehorses with owners who will ensure their health and safety.
Among the recommendations was a prohibition on corticosteroids joint injections within seven days of a race.
The move prefaces the implementation of a rule mandating the use of helmets while riding at FEI events.
This year’s ballot includes two horse health-related events.
Many leaders believe sweeping medication reform could become a reality in early 2013.
The changes are designed to prevent mistakes in Salix administration prior to races.
Racing regulators amended rules on the use of clenbuterol and methylprednisolone acetate in Thoroughbreds.
Economists are forecasting an upturn in equine receipts in 2013 after the industry saw steady sales in 2012.
Dr. Lisa Fortier recaps studies on upper respiratory tract health, colic, lameness, and racehorse health.
The Thoroughbred Charities of America appointed Eric Hamelback and Michael McMahon to its board of directors.
A panel discussed dealing with drug violators in horse racing and reported progress.
Attendees will work to find a solution to current import and export procedure problems.
The storm had a significant effect on wagering during the Nov. 2-3 Breeders’ Cup races, held in California.
Fans can vote for the seven nominees until Dec. 23.
Tim Morris, DVM, PhD, will leave the organization as part of the ongoing restructure of BHA services.
The winner of the Darley Prix Jean Romanet was disqualified after testing positive for an anti-inflammatory.
Stay on top of the most recent Horse Health news with
